Status:

WITHDRAWN

A Functional MRI Study: Assessing Brain Function in Post Stoke Patients

Lead Sponsor:

NeuroGlove LLC

Conditions:

Ischemic Stroke

Stroke

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

This is a prospective, single center, observational clinical study containing two cohorts the healthy cohort and post stroke cohort. A total of 13 subjects will be enrolled. Three (3) healthy voluntee...

Detailed Description

This is a prospective, single center, observational clinical study containing two cohorts the healthy cohort and post stroke cohort. A total of 13 subjects will be enrolled. Three (3) healthy voluntee...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Healthy Cohort):
  • Able and willing to provide informed consent. Men and women ≥18 and \<85 years of age. Subject must be right hand dominant. Subject should not have any physical limitations of either upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
  • Inclusion Criteria (Treatment Cohort):
  • Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
  • Men and women ≥18 and \<85 years of age. First single acute ischemic stroke with an onset date within 14 days (± 7 days from onset) of enrollment (time of informed consent) into the study.
  • Mild to moderate acute ischemic stroke defined as NIHSS score of 3 to 15. Measurable weakness of one upper extremity without complete paralysis (detectable movement in at least 3 fingers).
  • Subject must be right hand dominant. Subject should not have any physical limitations of either upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
  • Exclusion Criteria:
  • Coma, inability to cooperate with the study based on impaired level of consciousness or confusion.
  • Known neurological deficit prior to stroke (including but not limited to previous stroke, MS, Parkinson's disease).
  • Physical limitations of the weak upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.) Any contraindication to the imaging required per the protocol. Complete middle cerebral artery infarction based on imaging. Carotid artery stenosis \>50% of the normal diameter segment (diameter stenosis, compared to the angiographically normal proximal or distal segment).
  • Subjects has a known history of substance abuse (drug) or alcohol dependence, or lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
  • If female, subject is pregnant at the time of enrollment or planning to become pregnant during the trial period.
  • Subject has any other acute or chronic condition that the investigator believes will adversely affect the ability to interpret the data or will prevent the subject from completing the trial procedures.
  • Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)

Exclusion

    Key Trial Info

    Start Date :

    November 10 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 15 2024

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT06573840

    Start Date

    November 10 2024

    End Date

    November 15 2024

    Last Update

    August 27 2024

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.